World Market for Infectious Disease Immunoassays

Kalorama Information’s report, The World Market for Infectious Disease Immunoassays, provides important business planning data for companies in the immunoassay market, investing in the field, or considering expansion. The following are among the data provided in the report:

•  Global Lab-based Infectious Disease Immunoassay Sales 2016 [Hepatitis, HIV, STD, TORCH, Respiratory, HAIs, Other Infectious Disease (in millions$))
•  Global Lab-based Infectious Disease Immunoassay Market Share % 2016
•  Lab-Based Immunoassay Market by Geographic Region 2021
•  POC Infectious Disease Immunoassay Market
•  Lab-Based Immunoassay Infectious Disease Market by Country (US, Germany, France, UK, Italy, Spain, China, Brazil, Saudi Arabia, Turkey, Canada)
•  POC Infectious Disease Immunoassay Market by Country(US, Germany, France, UK, Italy, Spain, China, Brazil, Saudi Arabia, Turkey, Canada)
•  Trends and Information
•  Corporate Profiles

Some infectious disease immunoassays are being replaced with molecular assays. For example, most chlamydia and gonorrhea testing in developed countries is performed with molecular diagnostic assays rather than with immunoassays. A major driving factor in this conversion to molecular testing for chlamydia and gonorrhea was the increased sensitivity of these molecular tests compared to traditional immunoassays, and especially compared to traditional rapid tests such as lateral flow-based assays. However, many improvements have been made with immunoassays to improve the technical performance of these assays, including better sensitivity. Innovations in immunoassay technology and platforms have been discussed in Chapter 4, and many companies developing these new, innovative platforms are profiled in this report.